71406-63-8 Usage
Uses
Used in Pharmaceutical Industry:
N-Benzyl-4-chloropyrimidin-2-amine is used as a building block for the synthesis of biologically active molecules, contributing to the development of new drugs and therapeutic agents.
Used in Agrochemical Industry:
N-Benzyl-4-chloropyrimidin-2-amine is used as a precursor in the synthesis of agrochemicals, potentially leading to the creation of new pesticides or other agricultural chemicals that can improve crop protection and yield.
Used in Research and Development:
N-Benzyl-4-chloropyrimidin-2-amine is utilized in research and development efforts to explore its specific reactivity and biological activity due to its chlorine substitution, which may lead to novel applications and advancements in both pharmaceutical and agrochemical fields.
Check Digit Verification of cas no
The CAS Registry Mumber 71406-63-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,1,4,0 and 6 respectively; the second part has 2 digits, 6 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 71406-63:
(7*7)+(6*1)+(5*4)+(4*0)+(3*6)+(2*6)+(1*3)=108
108 % 10 = 8
So 71406-63-8 is a valid CAS Registry Number.
71406-63-8Relevant academic research and scientific papers
IMIDAZO-OXADIAZOLE AND IMIDAZO-THIADIAZOLE DERIVATIVES
-
Page/Page column 91; 92, (2014/01/08)
The present invention provides compounds of Formula (I) used as Amyloid beta lowering agent for the treatment of neurodegenerative diseases.
Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: Development of chemical probe ML315
Coombs, Thomas C.,Tanega, Cordelle,Shen, Min,Wang, Jenna L.,Auld, Douglas S.,Gerritz, Samuel W.,Schoenen, Frank J.,Thomas, Craig J.,Aubé, Jeffrey
supporting information, p. 3654 - 3661 (2013/07/05)
Substituted pyrimidine inhibitors of the Clk and Dyrk kinases have been developed, exploring structure-activity relationships around four different chemotypes. The most potent compounds have low-nanomolar inhibitory activity against Clk1, Clk2, Clk4, Dyrk
